These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 27773961)
1. KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer. Zhang S; Huang F; Wang Y; Song Q; Yang X; Wu H Dis Markers; 2016; 2016():7484516. PubMed ID: 27773961 [TBL] [Abstract][Full Text] [Related]
2. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer. Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867 [TBL] [Abstract][Full Text] [Related]
3. KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer. Zhang X; Wang Y; Liu X; Zhao A; Yang Z; Kong F; Sun L; Yu Y; Jiang L Biomed Pharmacother; 2020 May; 125():109840. PubMed ID: 32106376 [TBL] [Abstract][Full Text] [Related]
4. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer. Wang D; Zhu H; Ye Q; Wang C; Xu Y Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1-MMP. Zhao P; Lan F; Zhang H; Zeng G; Liu D Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1010-1018. PubMed ID: 29781531 [TBL] [Abstract][Full Text] [Related]
7. Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients. Wang G; Wang Z; Yu H J Clin Lab Anal; 2020 Apr; 34(4):e23135. PubMed ID: 31858647 [TBL] [Abstract][Full Text] [Related]
8. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer. Qi H; Wang Y Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015 [TBL] [Abstract][Full Text] [Related]
9. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression. Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330 [TBL] [Abstract][Full Text] [Related]
10. High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma. Xie T; Li X; Ye F; Lu C; Huang H; Wang F; Cao X; Zhong C Biochem Biophys Res Commun; 2018 Feb; 497(1):65-72. PubMed ID: 29427669 [TBL] [Abstract][Full Text] [Related]
11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
12. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer. Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493 [TBL] [Abstract][Full Text] [Related]
13. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC. Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555 [TBL] [Abstract][Full Text] [Related]
14. AKR1B10, a good prognostic indicator in gastric cancer. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159 [TBL] [Abstract][Full Text] [Related]
15. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas. Zhao Y; Zhang T; Wang Q Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849 [TBL] [Abstract][Full Text] [Related]
16. Kinesin family member 2A links with advanced tumor stage, reduced chemosensitivity and worse prognosis in gastric cancer. Bai F; He Z; Zhou H; Gan W J Clin Lab Anal; 2022 May; 36(5):e24313. PubMed ID: 35313389 [TBL] [Abstract][Full Text] [Related]
17. Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma. Xu X; Feng L; Liu Y; Zhou WX; Ma YC; Fei GJ; An N; Li Y; Wu X; Yao F; Cheng SJ; Lu XH World J Gastroenterol; 2014 Dec; 20(47):17883-93. PubMed ID: 25548486 [TBL] [Abstract][Full Text] [Related]
18. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
19. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer. Cheng Y; Yang B; Xi Y; Chen X Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161 [TBL] [Abstract][Full Text] [Related]
20. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]